Quantcast

Welichem Announces Changes of Directors

January 2, 2014

BURNABY, BC, Jan. 2, 2014 /CNW/ – Welichem Biotech Inc. (the “Company”)
(TSX-V: WBI), announced today that Ryan B. Zeng has been appointed as a
new director of the Company effective immediately.

Mr. Zeng has been serving as a senior manager of T&T Supermarket in
Richmond, British Columbia since 2008. He has extensive experience
and knowledge in computer sciences, company operation and management
from various industries including technology and supermarket companies
over more than 15 years. Mr. Zeng obtained his Bachelors Degree in
Computer Science from Jilin University (China) in 1998.

The Company also announced today that Mr. James Dai has resigned as a
director of the Company effective January 2, 2014. The Company has
valued the contribution of Mr. Dai as a director of the Company and
Chair of the Audit Committee over the past year and wishes his success
in his future endeavors.

About Welichem Biotech Inc.

Welichem Biotech Inc. is a publicly-traded biotechnology company
developing therapeutic drugs in the fields of autoimmune diseases and
cancer. For a more complete business and financial profile of the
Company, interested parties are encouraged to visit the Company’s
website, www.welichem.com.

The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this news
release. This press release contains forward-looking statements that
include our belief as to the potential of our products. Certain risks
and uncertainties such as our ability to successfully commercialize the
products could cause the Company’s actual results to differ materially
from those in the forward-looking statements.

SOURCE Welichem Biotech Inc.


Source: PR Newswire



comments powered by Disqus